EQS-News: VERBIO Vereinigte BioEnergie AG
/ Key word(s): Quarterly / Interim Statement
VERBIO AG makes a strong start in the new financial year
Leipzig, November 10, 2022 – Group revenues in the first three months of the financial year 2022/2023 total EUR 592.2 million (Q1 21/22: EUR 350.4 million), an increase of 69 percent compared to the same period in the previous year. The increase in sales revenues compared to the first quarter of the previous year is primarily due to the higher sales prices of both biodiesel and bioethanol. Earnings before interest, taxation, depreciation and amortisation (EBITDA) amounted to EUR 121.4 million, a 202 percent increase compared to the comparative period (Q1 21/22: EUR 40.2 million). The Group has net cash of EUR 261.9 million at the reporting date (June 30, 2022: EUR 284.1 million). Cash outflows for investments totalled EUR 39.6 million (Q1 21/22: EUR 20.2 million), primarily in connection with the projects to expand the biorefinery in Nevada, Iowa, to increase the Group’s capacity to manufacture advanced biofuels, and build o its own BioLNG/BioCNG infrastructure in Germany to optimise the Group’s value added chain. The equity ratio was 72.0 percent (June 30, 2022: 72.5 percent). More than proportionate increase in earnings in the Biodiesel segment In the Bioethanol segment VERBIO achieved record production volumes, producing 261.0 GWh of biomethane and 71,390 tonnes of bioethanol. Although it was not possible to maintain the sales and results levels seen in the previous quarter due to falling sales prices for bioethanol and seasonal effects on the quota business, sales revenues were higher than in the same quarter of the previous year, totalling EUR 152.8 million (Q1 21/22: EUR 86.0 million). EBITDA was EUR 28.9 million (Q1 21/22: EUR 17.1 million). Forecast confirmed Over the remaining course of the year VERBIO aims to accelerate investments in expanding production capacity, product diversification and internationalisation. Accordingly, the Management Board continues to expect net financial assets at the end of the financial year 2022/2023 to be approximately EUR 30 million. The forecast is made subject to the proviso that the continued course of the Russian aggression in Ukraine and its consequences do not have a significant further negative effect on the market for biofuels, and in particular on the procurement of raw materials and energy.
VERBIO key figures
Detailed information on business developments in the first three months of the 2022/2023 financial year is provided in the quarterly statement for the period ended September 30, 2022, which can be viewed from 8.30 a.m. CET on VERBIO’s website at www.verbio.de/financial-reports.
Information about VERBIO Vereinigte BioEnergie AG (VERBIO) VERBIO AG is one of the leading independent bioenergy manufacturers, and is also the only large-scale producer of biodiesel, bioethanol and biomethane in Europe. The Group has approximately 1,000 employees at its locations in Saxony, Saxony-Anhalt and Brandenburg as well as at its foreign subsidiaries in India, the USA, Canada, Poland and Hungary. VERBIO concentrates on the use of internally developed innovative technologies and efficient energy-saving production processes. VERBIO’s biofuels achieve CO2 savings of up to 90 percent compared to petrol or diesel. The Group’s annual production capacity amounts to approximately 660,000 tonnes of biodiesel, 300,000 tonnes of bioethanol and 1,300 gigawatt hours of biomethane. In addition, VERBIO manufactures biofertiliser and animal feed for agricultural use as well as high-value raw materials for the pharmaceutical, cosmetic and foodstuff industries. With its innovative processes and highly efficient production plants, VERBIO is a technology leader in the biofuels market. The VERBIO share (ISIN DE000A0JL9W6/WKN A0JL9W) has been listed in the prime standard segment of the Frankfurt Stock Exchange since October 2006.
Important notice This publication contains forward-looking statements that are based on assumptions and estimates made by the management of VERBIO Vereinigte BioEnergie AG. Although the Company’s management is of the opinion that these assumptions and estimations are realistic, actual future developments and actual future results may differ significantly from these assumptions and estimates due to a variety of factors. For example, these factors can include changes to the overall economic climate, changes to the legal and regulatory framework in Germany and the EU, and changes in the industry. VERBIO can give no guarantee and accepts no liability as to whether future development and the results actually achieved in future will match the assumptions and estimates made in this publication. Contact: VERBIO Vereinigte BioEnergie AG Ritterstraße 23 (Oelßner's Hof) 04109 Leipzig Alina Köhler(IR) Ulrike Kurze (PR) Tel: +49(0)341/308530-0 E-Mail: ir@verbio.de/pr@verbio.de
10.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | VERBIO Vereinigte BioEnergie AG |
Thura Mark 18 | |
06780 Zörbig | |
Germany | |
Phone: | +49 (0)341 308530-0 |
Fax: | +49 (0)341 308530-998 |
E-mail: | ir@verbio.de |
Internet: | www.verbio.de |
ISIN: | DE000A0JL9W6 |
WKN: | A0JL9W |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1483687 |
End of News | EQS News Service |
|
1483687 10.11.2022 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.